Open Access, Peer-reviewed

ISSN 2005-7571 (Online)
Volume 28, Number 1 (1/2021)
Review Article <page. 1-6 >
DOI : 10.22857/kjbp.2021.28.1.001

Current Pharmacogenetics in Psychiatry

Il Bin Kim, MD1,2; and Yu Sang Lee, MD3;

1;Department of Psychiatry, Hanyang University Guri Hospital, Guri, 2;Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, 3;Department of Psychiatry, Yong-In Mental Hospital, Yongin, Korea

Pharmacogenetics is opening a new era of precision medicine in psychiatry. Drug-metabolizing enzymes are characterized by genetic polymorphisms, which render a large portion of variability in individual drug metabolism. Dose adjustment based on pharmacogenetics knowledge is a first step to translate pharmacogenetics into clinical practice. However, diverse factors including cost-effectiveness should be addressed to provide clinical recommendation. To address current challenges in pharmacogenetics testing in psychiatry, this review provides an update regarding genotyping (SNP analysis, array, and next-generation sequencing), genotype-phenotype correlations, and cost-effectiveness. The current updates on pharmacogenetics in psychiatry will provide guidance for both clinician and researchers to have a consensus in harmonizing efforts to advance the pharmacogenetics field in a part of precision medicine in psychiatry.

Key words : Pharmacogenetics;Drug-metabolizing enzyme;CYP450;Genotyping;Psychiatry.


This Article